Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 216

The DOI matches its Crossref record.

N-Myc Downstream-Regulated Gene 4 ( NDRG4 ): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer

Open access
Melotte, Veerle, Lentjes, Marjolein H. F. M., van den Bosch, Sandra M., Hellebrekers, Debby M. E. I., de Hoon, Joep P. J., Wouters, Kim A. D., Daenen, Kathleen L. J., Partouns-Hendriks, Iris E. J. M., Stessels, Filip, Louwagie, Joost, Smits, Kim M., Weijenberg, Matty P., Sanduleanu, Silvia, Khalid-de Bakker, Carolina A. J., Oort, Frank A., Meijer, Gerrit A., Jonkers, Daisy M. A. E., Herman, James G., de Bruïne, Adriaan P., van Engeland, Manon·2009·JNCI: Journal of the National Cancer Institute

Abstract

BACKGROUND: Identification of hypermethylated tumor suppressor genes in body fluids is an appealing strategy for the noninvasive detection of colorectal cancer. Here we examined the role of N-Myc downstream-regulated gene 4 (NDRG4) as a novel tumor suppressor and biomarker in colorectal cancer. METHODS: NDRG4 promoter methylation was analyzed in human colorectal cancer cell lines, colorectal tissue, and noncancerous colon mucosa by using methylation-specific polymerase chain reaction (PCR) and bisulfite sequencing. NDRG4 mRNA and protein expression were studied using real-time-PCR and immunohistochemistry, respectively. Tumor suppressor functions of NDRG4 were examined by colony formation, cell proliferation, and migration and invasion assays in colorectal cancer cell lines that were stably transfected with an NDRG4 expression construct. Quantitative methylation-specific PCR was used to examine the utility of NDRG4 promoter methylation as a biomarker in fecal DNA from 75 colorectal cancer patients and 75 control subjects. All P values are two-sided. RESULTS: The prevalence of NDRG4 promoter methylation in two independent series of colorectal cancers was 86% (71/83) and 70% (128/184) compared with 4% (2/48) in noncancerous colon mucosa (P < .001). NDRG4 mRNA and protein expression were decreased in colorectal cancer tissue compared with noncancerous colon mucosa. NDRG4 overexpression in colorectal cancer cell lines suppressed colony formation (P = .014), cell proliferation (P < .001), and invasion (P < .001). NDRG4 promoter methylation analysis in fecal DNA from a training set of colorectal cancer patients and control subjects yielded a sensitivity of 61% (95% confidence interval [CI] = 43% to 79%) and a specificity of 93% (95% CI = 90% to 97%). An independent test set of colorectal cancer patients and control subjects yielded a sensitivity of 53% (95% CI = 39% to 67%) and a specificity of 100% (95% CI = 86% to 100%). CONCLUSIONS: NDRG4 is a candidate tumor suppressor gene in colorectal cancer whose expression is frequently inactivated by promoter methylation. NDRG4 promoter methylation is a potential biomarker for the noninvasive detection of colorectal cancer in stool samples.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djp131

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 216

Metadata

Authors
Melotte, V., Lentjes, M. H. F. M., van den Bosch, S. M., Hellebrekers, D. M. E. I., de Hoon, J. P. J., Wouters, K. A. D., Daenen, K. L. J., Partouns-Hendriks, I. E. J. M., Stessels, F., Louwagie, J., Smits, K. M., Weijenberg, M. P., Sanduleanu, S., Khalid-de Bakker, C. A. J., Oort, F. A., Meijer, G. A., Jonkers, D. M. A. E., Herman, J. G., de Bruïne, A. P., & van Engeland, M.
Venue
JNCI: Journal of the National Cancer Institute
Published
2009-07
Volume
101
Issue
13
Pages
916-927
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2163054923
Cited by
216
References
0
FWCI
5.52
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: N-Myc Downstream-Regulated Gene 4 ( NDRG4 ): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer. https://app.cochat.ai/papers/10.1093/jnci/djp131
The paper
Melotte, V., Lentjes, M. H. F. M., van den Bosch, S. M., Hellebrekers, D. M. E. I., de Hoon, J. P. J., Wouters, K. A. D., Daenen, K. L. J., Partouns-Hendriks, I. E. J. M., Stessels, F., Louwagie, J., Smits, K. M., Weijenberg, M. P., Sanduleanu, S., Khalid-de Bakker, C. A. J., Oort, F. A., Meijer, G. A., Jonkers, D. M. A. E., Herman, J. G., de Bruïne, A. P., & van Engeland, M. (2009). N-Myc Downstream-Regulated Gene 4 ( NDRG4 ): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djp131

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.